Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
A to Z Index
Follow FDA
FDA Voice Blog
Enter Search terms
Most Popular Searches
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
CVM Publications - Detail
FDA Home
CVM Publications
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
TITLE:
Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950-2002
AUTHORS:
Tadesse DA;Zhao S;Tong E;Ayers S;Singh A;Bartholomew MJ;McDermott PF;
YEAR:
2012
JOURNAL ABBREV:
Emerg Infect Dis
MONTH:
May
TYPE:
JOUR
REFMAN INDEX:
635
JOURNAL FULL:
Emerging infectious diseases
VOLUME:
18
ISSUE:
5
START PAGE:
741
END PAGE:
749
KEYWORDS:
Ampicillin;Animals;antimicrobial;Cattle;Chickens;COLI;drug;drug classes;Drug Resistance;DRUGS;Escherichia coli;ESCHERICHIA-COLI;Food;FOOD ANIMALS;GENTAMICIN;Humans;Maryland;multidrug resistance;MULTIDRUG-RESISTANCE;Phenotype;pigs;STRAIN;STRAINS;Streptomycin;SUSCEPTIBILITY;Tetracycline;United States;UNITED-STATES;
ABSTRACT:
We conducted a retrospective study of Escherichia coli isolates recovered from human and food animal samples during 1950-2002 to assess historical changes in antimicrobial drug resistance. A total of 1,729 E. coli isolates (983 from humans, 323 from cattle, 138 from chickens, and 285 from pigs) were tested for susceptibility to 15 antimicrobial drugs. A significant upward trend in resistance was observed for ampicillin (p<0.001), sulfonamide (p<0.001), and tetracycline (p<0.001). Animal strains showed increased resistance to 11/15 antimicrobial agents, including ampicillin (p<0.001), sulfonamide (p<0.01), and gentamicin (p<0.001). Multidrug resistance (>/=3 antimicrobial drug classes) in E. coli increased from 7.2% during the 1950s to 63.6% during the 2000s. The most frequent co-resistant phenotype observed was to tetracycline and streptomycin (29.7%), followed by tetracycline and sulfonamide (29.0%). These data describe the evolution of resistance after introduction of new antimicrobial agents into clinical medicine and help explain the range of resistance in modern E. coli isolates
AFFILIATIONS:
Food and Drug Administration, Laurel, Maryland 20708, USA
-
-